Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Active Malignancies”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)UnknownNCT00719303
What this trial is testing

Diet and Physical Activity Change or Usual Care in Improving Progression-Free Survival in Patients With Previously Treated Stage II, III, or IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Who this might be right for
Fallopian Tube Clear Cell AdenocarcinomaFallopian Tube Endometrioid AdenocarcinomaFallopian Tube Mucinous Adenocarcinoma+30 more
Gynecologic Oncology Group 1,070
Early research (Phase 1)Ended earlyNCT05080842
What this trial is testing

AC682 for the Treatment of Locally Advanced or Metastatic ER+ Breast Cancer

Who this might be right for
Breast Cancer
Accutar Biotechnology Inc 21
Early research (Phase 1)Looking for participantsNCT07746141
What this trial is testing

A First-in-Human Study Investigating BG-85738 Alone or in Combination With Other Antitumor Agents in Patients With Advanced or Metastatic Solid Tumors With Rat Sarcoma Virus (RAS) Mutations

Who this might be right for
RAS MutationAdvanced Solid TumorMetastatic Solid Tumor
BeOne Medicines 100
Early research (Phase 1)Looking for participantsNCT07617727
What this trial is testing

A Phase I Study of JSKN021 in Advanced Solid Tumors

Who this might be right for
Advanced Malignant Solid Tumors
Jiangsu Alphamab Biopharmaceuticals Co., Ltd 199
Testing effectiveness (Phase 2)Study completedNCT01962103
What this trial is testing

Study to Find a Safe Dose and Show Early Clinical Activity of Weekly Nab-paclitaxel in Pediatric Patients With Recurrent/ Refractory Solid Tumors

Who this might be right for
NeuroblastomaRhabdomyosarcomaEwing's Sarcoma+20 more
Celgene 107
Testing effectiveness (Phase 2)Looking for participantsNCT06969430
What this trial is testing

Assess the Safety, Tolerability, and Antileukemic Activity of Debio 1562M in Participants With Acute Myeloid Leukemia (AML)

Who this might be right for
Acute Myeloid Leukemia
Debiopharm International SA 154
Not applicableActive Not RecruitingNCT06396611
What this trial is testing

Exercise As Intervention in Chronic Lymphocytic Leukemia

Who this might be right for
Chronic Lymphocytic Leukemia
Universidade do Porto 11
Early research (Phase 1)Looking for participantsNCT05800665
What this trial is testing

A Study Evaluating the Safety, Pharmacokinetics, and Activity of RO7656594 In Participants With Advanced or Metastatic Prostate Cancer

Who this might be right for
Advanced Prostate CancerMetastatic Prostate Cancer
Genentech, Inc. 210
Early research (Phase 1)Study completedNCT02316171
What this trial is testing

CAVATAK (CVA21) in Non-muscle Invasive Bladder Cancer (VLA-012 CANON)

Who this might be right for
Non-muscle Invasive Bladder Cancer
Viralytics 16
Not applicableStudy completedNCT03233581
What this trial is testing

Improving Physical Activity in Young Adult Cancer Survivors

Who this might be right for
Physical ActivityQuality of Life
Seattle Children's Hospital 50
Testing effectiveness (Phase 2)Study completedNCT01909830
What this trial is testing

Gemcitabine in Combination With Pemetrexed Long Term Infusion in the Treatment of Pretreated Metastatic Colorectal Cancer Patients

Who this might be right for
Colorectal Cancer Metastatic
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS 18
Not applicableUnknownNCT06277830
What this trial is testing

Physical Activity Monitoring in Myasthenia Gravis

Who this might be right for
Myasthenia Gravis
Massachusetts General Hospital 20
Not applicableUnknownNCT03111771
What this trial is testing

Mitochondrial Activity and Myosteatosis in the Cachexia of Cancers of the Upper Aerodigestive Tract

Who this might be right for
Cancer of Upper Aerodigestive PathwaysCachexia
University Hospital, Clermont-Ferrand 60
Not applicableStudy completedNCT00851812
What this trial is testing

Exercise for Breast Cancer Patients (EXCAP)

Who this might be right for
Fatigue
University of Rochester 114
Early research (Phase 1)Study completedNCT04883957
What this trial is testing

Study of BGB-11417 in Adult Participants With Mature B-cell Malignancies

Who this might be right for
Mature B-cell Malignancies
BeiGene 64
Testing effectiveness (Phase 2)Study completedNCT00005041
What this trial is testing

R115777 in Treating Patients With Relapsed Small Cell Lung Cancer

Who this might be right for
Lung Cancer
NYU Langone Health
Not applicableStudy completedNCT05716542
What this trial is testing

Prehabilitation to Revolutionize Oncology: Telehealth Exercise for Cognitive Triumphs (The PROTECT Trial)

Who this might be right for
Breast CancerCancer of the Breast
Washington University School of Medicine 41
Early research (Phase 1)Study completedNCT01759056
What this trial is testing

Evaluation of an Oral Anti-TNF Antibody in Patients With Active Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
Avaxia Biologics, Incorporated 33
Not applicableActive Not RecruitingNCT06190600
What this trial is testing

Supervised Physical Activity in Young Women With Early Breast Cancer During Neoadjuvant Chemotherpy

Who this might be right for
Breast Cancer
The Greater Poland Cancer Centre 40
Early research (Phase 1)Looking for participantsNCT07376707
What this trial is testing

TGI-5 as Monotherapy and in Combination With Nivolumab in Subjects With Locally Advanced/Metastatic Solid Tumors

Who this might be right for
CRC (Colorectal Cancer)Melanoma (Skin Cancer)HCC - Hepatocellular Carcinoma+1 more
Hefei TG ImmunoPharma Co., Ltd. 194
Next Page